Shiu W, Dewar G, Leung N, Leung W T, Chan M, Tao M, Lui C, Chan C L, Lau W Y, Metreweli C
Department of Clinical Oncology, Chinese University, Hong Kong.
Oncology. 1990;47(3):241-5. doi: 10.1159/000226823.
Three hundred and forty cases of hepatocellular carcinoma in Hong Kong were studied for their clinical features, and various factors were analysed for their prognostic values. The clinical presentation was often vague and rather non-specific and a majority of patients were presented late and often unresectable. The overall median survival was 8 weeks. The Karnofsky performance scale and bilirubin level were the most important prognostic factors. The treated group survived longer than the untreated group.
对香港的340例肝细胞癌患者的临床特征进行了研究，并分析了各种因素的预后价值。临床表现往往模糊且缺乏特异性，大多数患者就诊时已属晚期，常常无法切除。总体中位生存期为8周。卡诺夫斯基功能状态评分和胆红素水平是最重要的预后因素。接受治疗的组比未接受治疗的组存活时间更长。
